David Watson

Insider Reports History

Entity
Individual
Location
6400 Westwind Way, Suite A, Crestwood, KY
Signature
David Watson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Watson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. General Counsel Common Stock 118K $1.55M $13.19 Sep 27, 2024 Direct
Apellis Pharmaceuticals, Inc. General Counsel Common Stock 70.1K $925K $13.19 Sep 27, 2024 Indirect Owner (The David O. Watson Irrevocable Trust of 2023)
Apellis Pharmaceuticals, Inc. General Counsel Common Stock 6.67K $87.9K $13.19 Sep 27, 2024 Indirect Owner (The Watson Education Trust)
Apellis Pharmaceuticals, Inc. General Counsel Common Stock 3.33K $44K $13.19 Sep 27, 2024 Indirect Owner (Custodial Account for Son)
Apellis Pharmaceuticals, Inc. General Counsel Stock Option (Right to Buy) 0 $0 $66.30 Mar 6, 2024 Direct

Insider Reports Filed by David Watson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Sep 27, 2024 2 $0 4 Sep 30, 2024 General Counsel
APLS Apellis Pharmaceuticals, Inc. Mar 6, 2024 2 $52.1K 4 Mar 8, 2024 General Counsel
APLS Apellis Pharmaceuticals, Inc. Feb 12, 2024 1 -$52.9K 4 Feb 13, 2024 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jan 29, 2024 1 -$58.1K 4 Jan 31, 2024 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jan 22, 2024 1 -$272K 4 Jan 23, 2024 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jan 16, 2024 3 $2.01M 4 Jan 17, 2024 General Counsel
APLS Apellis Pharmaceuticals, Inc. Dec 19, 2023 4 -$114K 4 Dec 20, 2023 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jul 3, 2023 1 -$766K 4 Jul 6, 2023 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jun 28, 2023 2 $0 4 Jun 29, 2023 General Counsel
APLS Apellis Pharmaceuticals, Inc. Apr 21, 2023 2 $0 4 Apr 24, 2023 General Counsel
APLS Apellis Pharmaceuticals, Inc. Feb 21, 2023 3 -$48.3K 4 Feb 22, 2023 General Counsel
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2023 1 -$27.2K 4 Feb 14, 2023 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jan 27, 2023 1 -$29.1K 4 Jan 30, 2023 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jan 20, 2023 1 -$106K 4 Jan 24, 2023 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jan 12, 2023 3 $1.99M 4 Jan 17, 2023 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jun 22, 2022 1 -$445K 4 Jun 23, 2022 General Counsel
APLS Apellis Pharmaceuticals, Inc. Apr 21, 2022 3 -$250K 4 Apr 27, 2022 General Counsel
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2022 1 -$23.1K 4 Feb 14, 2022 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jan 28, 2022 1 -$25.1K 4 Feb 1, 2022 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jan 21, 2022 2 $0 4 Jan 25, 2022 General Counsel
APLS Apellis Pharmaceuticals, Inc. Dec 31, 2021 1 $0 5 Feb 10, 2022 General Counsel
APLS Apellis Pharmaceuticals, Inc. Dec 27, 2021 1 -$58.2K 4 Dec 28, 2021 General Counsel
APLS Apellis Pharmaceuticals, Inc. Dec 22, 2021 11 -$216K 4 Dec 23, 2021 General Counsel
APLS Apellis Pharmaceuticals, Inc. Sep 10, 2021 2 $4.11K 4 Sep 13, 2021 General Counsel
APLS Apellis Pharmaceuticals, Inc. Jun 21, 2021 2 $2.11K 4 Jun 22, 2021 General Counsel
APLS Apellis Pharmaceuticals, Inc. May 28, 2021 2 $2.11K 4 Jun 1, 2021 General Counsel